Financial Counselors Inc. Sells 205,999 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Financial Counselors Inc. lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 85.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,713 shares of the medical instruments supplier’s stock after selling 205,999 shares during the quarter. Financial Counselors Inc.’s holdings in DENTSPLY SIRONA were worth $659,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at $26,000. MassMutual Private Wealth & Trust FSB raised its holdings in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 564 shares during the last quarter. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA in the third quarter valued at approximately $77,000. Finally, Quarry LP raised its stake in shares of DENTSPLY SIRONA by 455.0% during the 3rd quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after purchasing an additional 2,489 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $14.93 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $14.78 and a 52 week high of $33.22. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm’s 50-day simple moving average is $17.62 and its 200 day simple moving average is $20.19. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.29%. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms have issued reports on XRAY. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. UBS Group reduced their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Finally, Barrington Research dropped their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.